| Identification | Back Directory | [Name]
Cefdaloxime | [CAS]
80195-36-4 | [Synonyms]
Cefdaloxime
HOGISBSFFHDTRM-GHXIOONMSA-N
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(hydroxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, (6R,7R)- | [Molecular Formula]
C14H15N5O6S2 | [MDL Number]
MFCD00864960 | [MOL File]
80195-36-4.mol | [Molecular Weight]
413.43 |
| Hazard Information | Back Directory | [Uses]
Cefdaloxime is an orally administered cephalosporin that has activity against Haemophilus influenzae, a bacteria that causes meningitis in humans. Cefdaloxime is also the active metabolite of HR916K, a cephalosporin ester. | [Definition]
ChEBI: Cefdaloxime is a cephalosporin compound having methoxymethyl and [(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetyl]amino side-groups; a third-generation cephalosporin antibiotic. It has a role as an antibacterial drug. |
|
|